Cited by 89Stress Responses and CortisolEstrogen and related hormone effectsAdrenal Hormones and Disorders

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

Open access
Pariante, Carmine M, Kim, Richard B, Makoff, Andrew, Kerwin, Robert W·2003·British Journal of Pharmacology

Abstract

Incubation of LMCAT fibroblast cells with antidepressants potentiates glucocorticoid receptor (GR)‐mediated gene transcription in the presence of dexamethasone and cortisol, but not of corticosterone. We have shown that antidepressants do so by inhibiting the LMCAT cell membrane steroid transporter (which is virtually identical to the multidrug resistance P‐glycoprotein) and thus by increasing dexamethasone or cortisol intracellular concentrations. However, previous experiments with the antidepressant fluoxetine in the presence of dexamethasone have produced negative results (Pariante et al. (2001). Br. J. Pharmacol., 134, 1335–1343). We have since re‐examined the effects of fluoxetine on GR‐mediated gene transcription in the presence of dexamethasone. Moreover, we have examined the effects of fluoxetine on GR‐mediated gene transcription in the presence of cortisol and corticosterone, and on the intracellular accumulation of radioactive cortisol and corticosterone. Finally, we have examined the effects of fluoxetine on inhibition of P‐glycoprotein activity in Caco‐2 cells. We now find that fluoxetine (1–10 μM) enhances GR‐mediated gene transcription in the presence of dexamethasone and cortisol (+140–170%), but not of corticosterone, and increases the intracellular accumulation of 3 H‐cortisol (+5–15%), but not of 3 H‐corticosterone. Moreover, fluoxetine (10 μM) induces approximately 30% inhibition of PGP activity in Caco‐2 cells. Our results show that fluoxetine, like other antidepressants, inhibits membrane steroid transporters. British Journal of Pharmacology (2003) 139, 1111–1118. doi:10.1038/sj.bjp.0705357

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705357

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Wilson, J., Foster, D., Kronenberg, H. & Larsen, P. pp. 517 -664. Philadelphia: W.B. Saunders Company.

Cited by

Sorted by citations

Authors
Pariante, C. M., Kim, R. B., Makoff, A., & Kerwin, R. W.
Affiliations
  • King's College London (GB)
  • Vanderbilt University (US)
Corresponding author
Pariante, Carmine M
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-07
Volume
139
Issue
6
Pages
1111-1118
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2065124716
Cited by
89
References
45
Citations by year
2026: 1 · 2025: 3 · 2023: 5 · 2020: 2 · 2019: 3 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 6
FWCI
2.14
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
National Institute of General Medical Sciences (GM31304, P01GM031304)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
fluoxetine, antidepressants, glucocorticoid receptor, P-glycoprotein, multidrug resistance, dexamethasone, cortisol, corticosterone, Caco-2 cells
MeSH terms
Animals, Corticosterone, Fluoxetine, Humans, Hydrocortisone, Receptors, Glucocorticoid, Steroids, Antidepressive Agents, Second-Generation, Caco-2 Cells, Membrane Transport Proteins, Membrane Transport Modulators, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review